232 related articles for article (PubMed ID: 2496257)
1. Characterization of a plasminogen activator and its inhibitor in human mesangial cells.
Lacave R; Rondeau E; Ochi S; Delarue F; Schleuning WD; Sraer JD
Kidney Int; 1989 Mar; 35(3):806-11. PubMed ID: 2496257
[TBL] [Abstract][Full Text] [Related]
2. Thrombin regulates components of the fibrinolytic system in human mesangial cells.
Villamediana LM; Rondeau E; He CJ; Medcalf RL; Peraldi MN; Lacave R; Delarue F; Sraer JD
Kidney Int; 1990 Nov; 38(5):956-61. PubMed ID: 2125090
[TBL] [Abstract][Full Text] [Related]
3. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
Sakata Y; Okada M; Noro A; Matsuda M
J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
[TBL] [Abstract][Full Text] [Related]
4. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N
Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic activity and species of plasminogen activator in human tears.
Hayashi K; Sueishi K
Exp Eye Res; 1988 Feb; 46(2):131-7. PubMed ID: 3127227
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
[TBL] [Abstract][Full Text] [Related]
7. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies.
Rondeau E; Mougenot B; Lacave R; Peraldi MN; Kruithof EK; Sraer JD
Clin Nephrol; 1990 Feb; 33(2):55-60. PubMed ID: 2107050
[TBL] [Abstract][Full Text] [Related]
9. Diurnal variation of the fibrinolytic system.
Grimaudo V; Hauert J; Bachmann F; Kruithof EK
Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
[TBL] [Abstract][Full Text] [Related]
10. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
[TBL] [Abstract][Full Text] [Related]
11. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
Takeuchi T; Niiya K; Kubonishi I; Miyoshi I
Thromb Haemost; 1990 Apr; 63(2):259-64. PubMed ID: 2363126
[TBL] [Abstract][Full Text] [Related]
12. Secretion of plasminogen activator and its inhibitor by glomerular epithelial cells.
Iwamoto T; Nakashima Y; Sueishi K
Kidney Int; 1990 Jun; 37(6):1466-76. PubMed ID: 2113968
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 beta up-regulates the plasminogen activator/plasmin system in human mesangial cells.
Wilson HM; Haites NE; Reid FJ; Booth NA
Kidney Int; 1996 Apr; 49(4):1097-104. PubMed ID: 8691730
[TBL] [Abstract][Full Text] [Related]
14. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells.
Hagège J; Peraldi MN; Rondeau E; Adida C; Delarue F; Medcalf R; Schleuning WD; Sraer JD
Am J Pathol; 1992 Jul; 141(1):117-28. PubMed ID: 1632457
[TBL] [Abstract][Full Text] [Related]
16. Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.
Levin EG; Santell L
J Cell Biol; 1987 Dec; 105(6 Pt 1):2543-9. PubMed ID: 3121634
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
[TBL] [Abstract][Full Text] [Related]
18. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
Philips M; Juul AG; Thorsen S
Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
[TBL] [Abstract][Full Text] [Related]
19. Urokinase synthesis and binding by glomerular epithelial cells in culture.
Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD
Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052
[TBL] [Abstract][Full Text] [Related]
20. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
Ramsby ML; Kreutzer DL
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]